82 Recombinant Human Erythropoietin in the Treatment of Anaemia in Children With End-Stage Renal Failure Maintained by Haemodialysis

Pediatric Research - United States
doi 10.1203/00006450-198808000-00108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Non-Cardiac Benefits of Human Recombinant Erythropoietin in End Stage Renal Failure and Anaemia.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1993English

Response of Anaemia in Rheumatoid Arthritis to Treatment With Subcutaneous Recombinant Human Erythropoietin.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

Upper Extremity Problems and Functioning in Patients With End Stage Renal Failure Receiving Haemodialysis

Turk Osteoporoz Dergisi
EndocrinologyMetabolismDiabetes
2018English

Treating Renal Anaemia With Recombinant Human Erythropoietin: Practical Guidelines and a Clinical Algorithm.

BMJ
1990English

Hypertension in Chronic Renal Failure and End-Stage Renal Disease Patients Treated With Haemodialysis or Peritoneal Dialysis

Nephrology Dialysis Transplantation
MedicineTransplantationNephrology
2000English

Monitoring Erythropoietin Therapy for Anaemia of Chronic Renal Failure by Serum Erythropoietin Assays

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
1993English

Anaemia and Its Response to Treatment With Recombinant Human Erythropoietin in Chronic Kidney Disease Patients

West African Journal of Medicine
2010English

Treating Renal Anaemia With Erythropoietin

BMJ
1990English

Electrocardiogram Changes in Patients With End Stage Renal Disease on Chronic Haemodialysis

International Journal of Research in Medical Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy